Correlation Between Kiromic Biopharma and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Virax Biolabs Group, you can compare the effects of market volatilities on Kiromic Biopharma and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Virax Biolabs.
Diversification Opportunities for Kiromic Biopharma and Virax Biolabs
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kiromic and Virax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Virax Biolabs go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Virax Biolabs
If you would invest 82.00 in Virax Biolabs Group on November 3, 2024 and sell it today you would earn a total of 87.00 from holding Virax Biolabs Group or generate 106.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Kiromic Biopharma vs. Virax Biolabs Group
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Virax Biolabs Group |
Kiromic Biopharma and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Virax Biolabs
The main advantage of trading using opposite Kiromic Biopharma and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |